ReShape Lifesciences Inc. Quarterly Depreciation in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
ReShape Lifesciences Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q1 2024.
  • ReShape Lifesciences Inc. Depreciation for the quarter ending March 31, 2024 was $6K, a 83.8% decline year-over-year.
  • ReShape Lifesciences Inc. annual Depreciation for 2023 was $121K, a 63.3% decline from 2022.
  • ReShape Lifesciences Inc. annual Depreciation for 2022 was $330K, a 42.2% increase from 2021.
  • ReShape Lifesciences Inc. annual Depreciation for 2021 was $232K, a 1447% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6K -$31K -83.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $37K -$57K -60.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $94K +$87K +1243% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $7K -$93K -93% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q1 2020 $100K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.